Cornerstone reference
A free, single-page reference to the research peptides most commonly studied in the published peer-reviewed literature. Each entry summarises sequence, class, mechanism, half-life, stability and a primary citation, plus a link to the full reference page if we stock the compound. Last updated 29 April 2026 by Joe, founder.
Research use only. The compounds described on this page are supplied for in-vitro laboratory research. None of the content here is medical advice, dosing guidance or a recommendation for human use.
9 entries
5-Amino-1-methylquinolinium iodide
A small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT) characterised in metabolic and adipose-research literature. Not a peptide chemically (it is a methylquinolinium derivative) but commonly co-studied with peptide GLP-1 agonists in metabolic models.
ActRIIB-Fc; soluble activin receptor type IIB
A recombinant fusion protein consisting of the extracellular domain of ActRIIB linked to a human IgG Fc region. Studied in published literature as a myostatin / activin pathway antagonist with reported effects on skeletal muscle mass in preclinical models.
Adrenocorticotropic hormone; corticotropin
A 39-residue peptide hormone derived from the proopiomelanocortin (POMC) precursor. The canonical reference standard for melanocortin receptor (MC2R) and HPA-axis research, well-characterised across decades of endocrinology literature.
Combination GHRH / GHS research blend
A research-use blend formulation that pairs a GHRH analogue with a ghrelin-mimetic GH secretagogue. Studied in the GH-axis literature for the synergy between the two pathways converging on pituitary somatotrophs.
FTPP; CKGGRAKDC-GG-D(KLAKLAK)2
A peptidomimetic chimera that targets prohibitin on the surface of white adipose vasculature, characterised in published preclinical literature for adipose-specific apoptotic research models. Distinctive for its tissue-targeting domain rather than a receptor-agonist mechanism.
5-Aminoimidazole-4-carboxamide ribonucleotide; Acadesine
A nucleoside analogue and AMPK activator widely characterised in metabolic-research literature. Not a peptide chemically (it is an adenosine analogue) but commonly studied alongside peptide metabolic compounds because of its distinct AMPK-mediated mechanism.
Anti-obesity drug 9604; hGH 177-191 fragment analogue
A 16-amino-acid synthetic fragment analogue of the C-terminus of human growth hormone (residues 177-191), with a tyrosine added at the N-terminus. Studied in published metabolic literature for lipolytic activity decoupled from the somatogenic effects of full-length GH.
Cibinetide; ARA-290; Helix B Surface Peptide
An 11-amino-acid synthetic peptide derived from the helix B surface of erythropoietin (EPO) and engineered to bind the heteromeric tissue-protective receptor (EPOR/CD131) without the haematopoietic activity of EPO itself. Characterised in inflammation and tissue-repair literature.
AT-II
An octapeptide hormone of the renin-angiotensin system (RAS), one of the most extensively cited reference peptides in cardiovascular and renal pharmacology. Listed here as a reference; stocked separately as a research-grade reference standard from specialist suppliers.
2 entries
Body Protection Compound-157; Pentadecapeptide BPC-157
A 15-amino-acid synthetic peptide derived from a partial sequence of human gastric juice protein. One of the most widely cited regenerative-research peptides, characterised in extensive preclinical literature for tendon, gut-mucosal and connective-tissue repair models.
Vitamin B12; Mecobalamin
The methylated, biologically active form of vitamin B12 used as a research reference standard in metabolic, neurological and haematology pharmacology. Not a peptide chemically (it is a corrin-cobalt complex) but supplied as a research-grade reagent alongside the peptide catalogue.
3 entries
AM833
A long-acting amylin analogue characterised in published metabolic-research literature, frequently studied in combination with semaglutide as a dual-mechanism research compound. Acts at amylin and calcitonin receptor family targets.
Drug Affinity Complex GHRH analogue
A modified 30-amino-acid GHRH analogue carrying a maleimidopropionic acid (DAC) moiety that covalently binds serum albumin, dramatically extending the half-life relative to native GHRH or unmodified analogues. Widely cited in long-acting GH-axis research.
Modified GRF 1-29; ModGRF
The same modified GHRH backbone as CJC-1295 (DAC) but lacking the albumin-binding maleimide. Half-life is approximately 30 minutes, longer than native GHRH(1-29) but much shorter than the DAC-modified version. Widely cited in pulsatile GH-research.
2 entries
Delta Sleep-Inducing Peptide
A 9-amino-acid neuropeptide originally isolated from rabbit cerebral venous blood and characterised in CNS / sleep-architecture research literature. The mechanism in published research is not fully resolved; multiple receptor-system interactions are reported.
LY2189265
A long-acting GLP-1 receptor agonist consisting of two GLP-1(7-37) analogue molecules covalently linked to a modified human IgG4 Fc fragment. Characterised across published incretin pharmacology literature.
2 entries
Epitalon; AEDG tetrapeptide
A short 4-amino-acid synthetic peptide originating from research at the St Petersburg Institute of Bioregulation and Gerontology. Characterised in published Russian literature for telomerase / pineal-gland research models.
Exendin-4
A 39-amino-acid peptide originally isolated from the salivary secretions of the Gila monster (Heloderma suspectum) and acting as a GLP-1 receptor agonist with greater enzymatic stability than native GLP-1. One of the most extensively cited GLP-1 reference compounds in incretin literature.
2 entries
FOXO4 D-Retro-Inverso peptide
A D-amino-acid retro-inverso peptide engineered to disrupt the FOXO4-p53 interaction, characterised in published senescence-research literature for selective senolytic activity in preclinical models.
FST-315; FST-344
An autocrine glycoprotein characterised in published myostatin / activin signalling literature as an antagonist of activin and myostatin via direct binding. Both 315-residue and 344-residue isoforms are studied.
5 entries
Copper Tripeptide-1; Glycyl-L-histidyl-L-lysine:copper
A tripeptide-copper complex consisting of glycyl-L-histidyl-L-lysine bound to a Cu²⁺ ion. One of the most extensively cited regenerative-research peptides, with hundreds of publications spanning copper biochemistry, collagen synthesis, and dermal-research models.
Growth Hormone Releasing Peptide-2; Pralmorelin
A 6-amino-acid synthetic ghrelin-mimetic GH secretagogue acting on the growth-hormone secretagogue receptor (GHS-R). One of the canonical reference compounds in GHS-R research alongside GHRP-6 and Hexarelin.
Growth Hormone Releasing Peptide-6
A 6-amino-acid synthetic GH secretagogue and the original ghrelin-mimetic discovered before the endogenous ligand ghrelin was identified. Acts on GHS-R1a; characterised across decades of GH-axis literature.
GSH; reduced glutathione; gamma-Glu-Cys-Gly
A 3-amino-acid intracellular tripeptide (gamma-Glu-Cys-Gly) and the principal endogenous low-molecular-weight thiol antioxidant in mammalian cells. Widely used as a reference standard in redox-biology research.
GnRH; LHRH; Gonadotropin-Releasing Hormone
A 10-amino-acid hypothalamic decapeptide and the natural ligand for the GnRH receptor on pituitary gonadotrophs. The canonical reference standard for HPG-axis pharmacology research.
3 entries
Human Chorionic Gonadotropin
A heterodimeric glycoprotein hormone with an alpha subunit shared with LH/FSH/TSH and a beta subunit specific to HCG. The canonical reference standard for LH receptor pharmacology research.
Human Growth Hormone; Somatotropin; Recombinant hGH 1-191
A 191-amino-acid recombinant human growth hormone identical in sequence to the endogenous pituitary peptide. The canonical reference standard for GH receptor / JAK2-STAT5 signalling research.
Examorelin
A 6-amino-acid synthetic GH secretagogue closely related to GHRP-6, characterised in published GH-axis literature. Reported in research as having additional CD36-mediated cardiovascular activity beyond GHS-R1a binding.
2 entries
Long R3 IGF-1; Long Arg3 Insulin-like Growth Factor-1
A 83-amino-acid analogue of IGF-1 with an additional 13-residue N-terminal extension and an arginine substitution at position 3. Reduced binding to IGF binding proteins gives an extended half-life relative to native IGF-1.
NNC 26-0161
A 5-amino-acid selective ghrelin-mimetic GH secretagogue. Distinct from GHRP-2 and GHRP-6 in that the published profile reports minimal cortisol or prolactin release, making it the most selective GHS-R1a compound for research purposes.
No common entries
No widely-cited research peptides start with J. The closest reference standards are Jasplakinolide (an actin-stabilising marine cyclic peptide used in cell biology) and Jingzhaotoxin (a spider toxin used in ion-channel research) - neither is supplied as a research-peptide reference.
2 entries
Metastin 45-54; Kp-10
The C-terminal 10-amino-acid fragment of the 54-residue Kisspeptin-54 / Metastin precursor and a high-affinity ligand at the GPR54 (KISS1R) receptor. The canonical reference compound for hypothalamic-pituitary-gonadal (HPG) axis research.
Kisspeptin / Lipid / Oxytocin / WAT-targeting research blend
A research-use blend formulation studied for parallel multi-pathway research models. Composition is supplied with the order; refer to the product page for the precise blend ratio of the current batch.
2 entries
NN2211
A long-acting GLP-1 receptor agonist consisting of a GLP-1(7-37) analogue with a fatty acid (palmitic acid) attached via a glutamic acid spacer at Lys26. The fatty-acid acylation enables albumin binding and extends the half-life relative to native GLP-1.
Cathelicidin antimicrobial peptide; CAMP
A 37-amino-acid host-defence peptide processed from the human cathelicidin precursor hCAP-18. Characterised across innate-immunity literature for broad antimicrobial and immunomodulatory activity.
6 entries
IBI362; LY3305677
A GLP-1 / glucagon dual receptor agonist characterised in published Phase 2 metabolic-research literature. Distinct from triple agonists (e.g., Retatrutide) by lacking GIP activity.
N-acetyl-5-methoxytryptamine
An endogenous indoleamine derived from serotonin via N-acetylation and O-methylation, secreted by the pineal gland. Not a peptide chemically but supplied as a research reference standard for circadian and antioxidant research alongside the peptide catalogue.
Mitochondrial-derived peptide
A 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. Characterised in metabolic-research literature for AMPK-mediated effects in skeletal muscle and adipose models.
Melanotan-1; NDP-MSH; [Nle&sup4;, D-Phe⁷]-α-MSH
A 13-amino-acid synthetic analogue of alpha-melanocyte-stimulating hormone with a norleucine-4 and D-phenylalanine-7 substitution that increases potency and metabolic stability at melanocortin receptors.
Melanotan-II; Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂
A 7-amino-acid cyclic synthetic analogue of alpha-MSH with a lactam bridge between Asp² and Lys⁷. The cyclic structure provides metabolic stability and broad melanocortin receptor agonism.
Mechano Growth Factor; IGF-1Ec splice variant
A splice variant of the IGF-1 gene producing a 24-amino-acid C-terminal peptide called MGF, characterised in published muscle-research literature for its role in mechanical-load-induced satellite cell activation. PEG-MGF refers to the polyethylene-glycolated stabilised form.
1 entry
Nicotinamide adenine dinucleotide
A pyridine dinucleotide cofactor essential to redox metabolism, energy production and sirtuin / PARP signalling. Not a peptide chemically (it is a dinucleotide) but supplied as a research-grade reference standard alongside the peptide catalogue. Widely cited in mitochondrial and ageing-research literature.
1 entry
OXT
A 9-amino-acid cyclic neuropeptide hormone with a disulfide bridge between Cys1 and Cys6. Synthesised in the hypothalamus and released from the posterior pituitary; the canonical reference peptide for social-bonding, reproductive and CNS research.
1 entry
Bremelanotide; PT141
A cyclic 7-amino-acid heptapeptide melanocortin agonist derived from MT-2 by replacing the C-terminal amide with a free carboxylic acid. Characterised in published literature for selectivity towards MC4R / MC3R relative to MC1R.
No common entries
No widely-cited research peptides start with Q.
1 entry
LY3437943
A 39-amino-acid synthetic peptide and triple agonist at the GLP-1, GIP and glucagon receptors. Characterised in published Phase 2 metabolic-research literature with the largest reported weight-related outcomes of any single-compound incretin programme to date.
4 entries
TP-7-tuftsin analogue
A 7-amino-acid synthetic peptide originating from research at the V.V. Zakusov Research Institute of Pharmacology. A heptapeptide analogue of the immunomodulatory tetrapeptide tuftsin, characterised in published literature for anxiolytic and GABAergic research.
NN9535
A 31-amino-acid GLP-1 receptor agonist with two amino acid substitutions and a fatty-diacid acylation that enables strong albumin binding. The most extensively cited single-target GLP-1 agonist in current metabolic-research literature.
Met-Glu-His-Phe-Pro-Gly-Pro; Russian nootropic peptide
A 7-amino-acid synthetic peptide derived from the ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro tripeptide added for enzymatic stability. Characterised in published Russian neuroscience literature for BDNF / NGF modulation in CNS-research models.
GHRH(1-29); GRF(1-29)
A 29-amino-acid synthetic peptide corresponding to the first 29 residues of native human growth-hormone-releasing hormone. The canonical reference standard for GHRH receptor pharmacology research.
4 entries
Thymosin Beta-4 fragment; LKKTETQ-related
A synthetic fragment representing the active region of full-length Thymosin Beta-4 (the actin-binding 17-LKKTETQ-23 motif and surrounding residues). Characterised in published literature for actin sequestration and angiogenesis-related tissue-repair models.
TH9507; trans-3-hexenoyl-GHRH(1-44)NH₂
A 44-amino-acid GHRH analogue corresponding to native human GHRH(1-44) with a trans-3-hexenoyl moiety attached to the N-terminus to enhance enzymatic stability. Characterised in published literature for adipose-distribution research models.
Tα1; Thymalfasin
A 28-amino-acid acetylated peptide derived from the prothymosin alpha precursor, originally isolated from bovine thymic extracts. Widely cited in immunomodulatory research as a TLR-9 / TLR-2 modulator.
LY3298176
A 39-amino-acid synthetic peptide and dual agonist at the GIP and GLP-1 receptors with a C20 fatty-diacid moiety enabling albumin binding. The most cited dual incretin reference compound in current metabolic-research literature.
No common entries
No widely-cited research peptides start with U.
1 entry
Vasoactive Intestinal Polypeptide
A 28-amino-acid peptide hormone of the secretin / glucagon superfamily, released from neurons throughout the central and peripheral nervous system. The reference standard for VPAC1 / VPAC2 receptor research.
No common entries
No widely-cited research peptides start with W.
No common entries
No widely-cited research peptides start with X.
No common entries
No widely-cited research peptides start with Y.
No common entries
No widely-cited research peptides start with Z.
This Bible is maintained by Joe, founder of Black & White Peptides Ltd. The data shown is drawn from the published peer-reviewed literature: PubMed primary research, ChemSpider / PubChem chemistry data, and where applicable the published patent record. Half-lives and molecular weights are rounded to literature precision and should be confirmed against your own laboratory characterisation before use.
If you spot an error or want a compound added to the next update, message us on WhatsApp +44 7886 853464 or email info@blackandwhitepeptides.co.uk. Real human reply, usually within working hours the same day.
Next pages to read: New to research peptides? Start here · What HPLC actually means · UK legal framework for research peptides · Blog